• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Mylan, Inc. (MYL)

    -NasdaqGS
    53.15 Down 1.73(3.16%) Jan 30, 4:00PM EST
    |After Hours : 53.15 0.00 (0.00%) Jan 30, 5:47PM EST
    Add to Portfolio
    Prev Close:54.88
    Open:54.25
    Bid:50.05 x 100
    Ask:N/A
    1y Target Est:59.63
    Beta:0.69
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:53.01 - 55.00
    52wk Range:42.43 - 59.60
    Volume:6,399,419
    Avg Vol (3m):3,411,690
    Market Cap:19.89B
    P/E (ttm):23.01
    EPS (ttm):2.31
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MYL

    Comparison

    Symbol% ChgMkt Cap
    MYLDown 3.16%19.89B
    ACTDown 2.46%70.65B
    TEVADown 1.22%48.60B

    Key Statistics

    Forward P/E (1 yr):12.78
    P/S (ttm):2.76
    Ex-Dividend Date:27-Jun-07

    Analysts

    Annual EPS Est (Dec-14) :3.56
    Quarterly EPS Est (Dec-14) :1.04
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mylan Inc., a pharmaceutical company, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback